Published in Ann Thorac Surg on November 07, 2012
Outcomes and predictors of early mortality after continuous-flow left ventricular assist device implantation as a bridge to transplantation. ASAIO J (2014) 0.91
Initial experience in Japan with HeartWare ventricular assist system. J Artif Organs (2014) 0.78
Invited commentary. Ann Thorac Surg (2012) 0.75
A retrospective evaluation of fondaparinux for confirmed or suspected heparin-induced thrombocytopenia in left-ventricular-assist device patients. J Cardiothorac Surg (2014) 0.75
How to cope with a temporarily aborted transplant program: solutions for a prolonged waiting period. Ann Transl Med (2015) 0.75
Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure -1 year results from the Ce mark trial. J Cardiothorac Surg (2017) 0.75
Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation (2004) 2.77
High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation (2006) 2.58
Impact of a molecular approach to improve the microbiological diagnosis of infective heart valve endocarditis. Circulation (2005) 2.51
Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT. J Nucl Med (2012) 2.25
Rapamycin extends murine lifespan but has limited effects on aging. J Clin Invest (2013) 2.23
Impact of transcatheter aortic valve implantation or surgical aortic valve replacement on right ventricular function. Heart (2012) 2.03
Impact of transcatheter aortic valve implantation or surgical aortic valve replacement on right ventricular function--the reply. Heart (2012) 1.98
Dynamic regulation of MEK/Erks and Akt/GSK-3beta in human end-stage heart failure after left ventricular mechanical support: myocardial mechanotransduction-sensitivity as a possible molecular mechanism. Cardiovasc Res (2003) 1.91
Left ventricular pressure and volume unloading during pulsatile versus nonpulsatile left ventricular assist device support. Ann Thorac Surg (2004) 1.89
Chronic kidney disease in patients with chronic heart failure--impact on intracardiac conduction, diastolic function and prognosis. Int J Cardiol (2006) 1.80
Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes. J Cardiovasc Electrophysiol (2007) 1.68
Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices. Ann Thorac Surg (2007) 1.64
Cardiac tumors--diagnosis and surgical treatment. Dtsch Arztebl Int (2014) 1.61
Acute inhibition of the Na(+)/Ca(2+) exchanger reduces proarrhythmia in an experimental model of chronic heart failure. Heart Rhythm (2011) 1.54
Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up. Heart Rhythm (2005) 1.50
Long-term support of 9 patients with the DeBakey VAD for more than 200 days. J Thorac Cardiovasc Surg (2005) 1.50
Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome: a long-term follow-up. Europace (2011) 1.47
Phytanic acid accumulation is associated with conduction delay and sudden cardiac death in sterol carrier protein-2/sterol carrier protein-x deficient mice. J Cardiovasc Electrophysiol (2004) 1.43
Everolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients. Atherosclerosis (2013) 1.41
Direct epicardial mapping predicts the recovery of left ventricular dysfunction in chronic ischaemic myocardium. Eur Heart J (2004) 1.39
Usefulness of tissue Doppler imaging for estimation of filling pressures in patients with primary or secondary pure mitral regurgitation. Am J Cardiol (2004) 1.18
Clinical and echocardiographic outcomes after implantation of the Trifecta aortic bioprosthesis: an initial single-centre experience. Interact Cardiovasc Thorac Surg (2012) 1.18
Survivin determines cardiac function by controlling total cardiomyocyte number. Circulation (2008) 1.18
Treatment of thrombus formation associated with the MicroMed DeBakey VAD using recombinant tissue plasminogen activator. Circulation (2002) 1.16
Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3. Cardiovasc Res (2005) 1.15
Systematic analysis of gene expression differences between left and right atria in different mouse strains and in human atrial tissue. PLoS One (2011) 1.15
G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis. J Exp Med (2006) 1.13
The natriuretic peptide/guanylyl cyclase--a system functions as a stress-responsive regulator of angiogenesis in mice. J Clin Invest (2009) 1.13
Role for staphylococci in misguided thrombus resolution of chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol (2008) 1.11
Hemodynamic support by left ventricular assist devices reduces cardiomyocyte DNA content in the failing human heart. Circulation (2010) 1.09
Selective coronary artery plaque visualization and differentiation by contrast-enhanced inversion prepared MRI. Eur Heart J (2006) 1.09
Rapamycin: brain excitability studied in vitro. Epilepsia (2007) 1.09
Patients with Fabry disease after enzyme replacement therapy dose reduction versus treatment switch. J Am Soc Nephrol (2014) 1.07
First clinical experience with the Incor left ventricular assist device. J Heart Lung Transplant (2005) 1.03
Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure. Cardiovasc Res (2004) 1.03
Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness. Crit Care Med (2009) 1.01
Pre-operative prediction of post-VAD implant mortality using easily accessible clinical parameters. J Heart Lung Transplant (2009) 1.00
Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer. Lung Cancer (2002) 1.00
Protein phosphatase 2A affects myofilament contractility in non-failing but not in failing human myocardium. J Muscle Res Cell Motil (2011) 1.00
Crossing atrial thrombus in a patient with recurrent pulmonary embolism. Crit Care Med (2002) 0.98
Transgenic triadin 1 overexpression alters SR Ca2+ handling and leads to a blunted contractile response to beta-adrenergic agonists. Cardiovasc Res (2004) 0.97
Thoracic epidural analgesia with low concentration of bupivacaine induces thoracic and lumbar sympathetic block: a randomized, double-blind clinical trial. Anesthesiology (2008) 0.96
Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease. Am J Cardiol (2008) 0.95
Hypervolemic hypertension in mice with systemic inactivation of the (floxed) guanylyl cyclase-A gene by alphaMHC-Cre-mediated recombination. Genesis (2004) 0.95
PKC delta-induced activation of MAPK pathway is required for bFGF-stimulated proliferation of coronary smooth muscle cells. Cardiovasc Res (2005) 0.95
Hyperglycemic kidney damage in an animal model of prolonged critical illness. Kidney Int (2009) 0.95
Prognostic value of tissue Doppler imaging in patients with chronic congestive heart failure. Int J Cardiol (2005) 0.94
Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice. FASEB J (2006) 0.94
Granulocyte colony-stimulating factor-induced blood stem cell mobilisation in patients with chronic heart failure--Feasibility, safety and effects on exercise tolerance and cardiac function. Basic Res Cardiol (2005) 0.93
A sweet debate: glycemic control in the intensive care unit. Crit Care Med (2008) 0.93
Granulocyte macrophage colony-stimulating factor deficiency affects vascular elastin production and integrity of elastic lamellae. J Vasc Res (2007) 0.93
Alterations in the vascular extracellular matrix of granulocyte macrophage colony-stimulating factor (GM-CSF) -deficient mice. FASEB J (2003) 0.92
Acute myocardial infarction as the first manifestation of left atrial myxoma. AJR Am J Roentgenol (2004) 0.92
Splenectomy is modifying the vascular remodeling of thrombosis. J Am Heart Assoc (2014) 0.92
Hypoglycemia aggravates critical illness-induced neurocognitive dysfunction. Diabetes Care (2009) 0.91
Cardiopulmonary bypass during cardiac surgery modulates systemic inflammation by affecting different steps of the leukocyte recruitment cascade. PLoS One (2012) 0.91
Outcome of patients surviving to heart transplantation after being mechanically bridged for more than 100 days. J Heart Lung Transplant (2003) 0.91
A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure. Eur J Heart Fail (2011) 0.91
Incidence of complications in patients with implantable cardioverter/defibrillator who receive additional transvenous pace/sense leads. Pacing Clin Electrophysiol (2005) 0.90
Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure. Eur J Heart Fail (2012) 0.90
Expression of thyroid hormone transporters during critical illness. Eur J Endocrinol (2009) 0.90
The interleukin-6/interleukin-6-receptor system is activated in donor hearts. J Am Coll Cardiol (2002) 0.90
Comparison of 3D segmented gradient-echo and steady-state free precession coronary MRI sequences in patients with coronary artery disease. AJR Am J Roentgenol (2005) 0.90
Tissue deiodinase activity during prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone-releasing peptide-2. Endocrinology (2005) 0.88
Efficacy of intravenous paracetamol compared to dipyrone and parecoxib for postoperative pain management after minor-to-intermediate surgery: a randomised, double-blind trial. Eur J Anaesthesiol (2011) 0.88
Bilateral ultrasound-guided axillary plexus anesthesia in a child with dystrophic epidermolysis bullosa. Paediatr Anaesth (2012) 0.88
Cell type-specific functions of the lysosomal protease cathepsin L in the heart. J Biol Chem (2007) 0.87
The heart-allocation simulation model: a tool for comparison of transplantation allocation policies. Transplantation (2003) 0.87
Brainstem involvement as a cause of central sleep apnea: pattern of microstructural cerebral damage in patients with cerebral microangiopathy. PLoS One (2013) 0.87
Skeletonization versus pedicle preparation of the radial artery with and without the ultrasonic scalpel. Ann Thorac Surg (2004) 0.87
Reversible pulmonary hypertension in heart transplant candidates--pretransplant evaluation and outcome after orthotopic heart transplantation. Eur J Heart Fail (2003) 0.86
Doppler microembolic load predicts risk of thromboembolic complications in Novacor patients. J Thorac Cardiovasc Surg (2003) 0.86
Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodelling. Cardiovasc Res (2011) 0.86
Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illness. Crit Care (2009) 0.86
Cardiac and ocular pathologies in a mouse model of mucopolysaccharidosis type VI. Pediatr Res (2003) 0.86
Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant. Ann Thorac Surg (2006) 0.86
Right-to-left-shunts detected by transesophageal echocardiography and transcranial Doppler sonography. Cerebrovasc Dis (2003) 0.86
Anticancer therapy by tumor vessel infarction with polyethylene glycol conjugated retargeted tissue factor. J Med Chem (2013) 0.85
Surgical approach to end-stage heart failure. Curr Opin Anaesthesiol (2011) 0.85
High level of cerebral microembolization in patients supported with the DeBakey left ventricular assist device. J Thorac Cardiovasc Surg (2005) 0.85
Ischemic preconditioning by unstable angina reduces the release of CK-MB following CABG and stimulates left ventricular HSP-72 protein expression. J Card Surg (2005) 0.84
Evaluation of bactec mycosis IC/F and Plus Aerobic/F blood culture bottles for detection of Candida in the presence of antifungal agents. J Clin Microbiol (2013) 0.84
Biochemical mechanisms of hibernation and stunning in the human heart. Cardiovasc Res (2002) 0.84
Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signalling. Cardiovasc Res (2013) 0.84
Longitudinal left ventricular 2D strain is superior to ejection fraction in predicting myocardial recovery and symptomatic improvement after aortic valve implantation. Int J Cardiol (2012) 0.84
The use of reinforcement learning algorithms to meet the challenges of an artificial pancreas. Expert Rev Med Devices (2013) 0.83
Renal effects of saline-based 10% pentastarch versus 6% tetrastarch infusion in ovine endotoxemic shock. Anesthesiology (2010) 0.83